We are live on ! Find out more
ETC

Exchange Traded Concepts Portfolio holdings

AUM $21.9B
1-Year Est. Return 68.6%
This Fund
S&P 500
This Quarter Est. Return
+14.78%
1 Year Est. Return
+68.6%
3 Year Est. Return
+158.93%
5 Year Est. Return
+186.62%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$210M
Cap. Flow
-$188M
Cap. Flow %
-5.03%
Top 10 Hldgs %
16.39%
Holding
1,456
New
147
Increased
521
Reduced
429
Closed
232

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Energy 12.45%
3 Healthcare 10.2%
4 Communication Services 6.83%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
326
Corcept Therapeutics
CORT
$10.1B
$1.44M 0.04%
44,448
+641
+1% +$17.6K
BKE icon
327
Buckle
BKE
$2.35B
$1.43M 0.04%
30,106
-1,885
-6% -$71.3K
UTL icon
328
Unitil
UTL
$1.01B
$1.43M 0.04%
27,129
+215
+0.8% +$10.4K
SAFT icon
329
Safety Insurance
SAFT
$1.51B
$1.42M 0.04%
18,647
+148
+0.8% +$11.2K
BYD icon
330
Boyd Gaming
BYD
$6.78B
$1.41M 0.04%
+22,569
New +$1.34M
SPTN
331
DELISTED
SpartanNash
SPTN
$1.39M 0.04%
60,598
+481
+0.8% +$10.9K
ATNI icon
332
ATN International
ATNI
$370M
$1.39M 0.04%
35,645
+283
+0.8% +$9.35K
TWI icon
333
Titan International
TWI
$530M
$1.37M 0.04%
92,081
-2,656
-3% -$35K
HUM icon
334
Humana
HUM
$46.7B
$1.35M 0.04%
2,950
+67
+2% +$33K
LMAT icon
335
LeMaitre Vascular
LMAT
$2.34B
$1.34M 0.04%
23,656
+187
+0.8% +$9.8K
ARWR icon
336
Arrowhead Research
ARWR
$12.1B
$1.34M 0.04%
+43,752
New +$1.16M
MRNA icon
337
Moderna
MRNA
$22.1B
$1.33M 0.04%
13,380
+659
+5% +$55.4K
ADUS icon
338
Addus HomeCare
ADUS
$2.23B
$1.33M 0.04%
14,310
+113
+0.8% +$9.82K
AMPH icon
339
Amphastar Pharmaceuticals
AMPH
$888M
$1.33M 0.04%
21,440
+169
+0.8% +$8.88K
HRMY icon
340
Harmony Biosciences
HRMY
$2.07B
$1.32M 0.04%
40,889
+328
+0.8% +$9.15K
PATK icon
341
Patrick Industries
PATK
$2.91B
$1.32M 0.04%
19,670
-867
-4% -$47.6K
TR icon
342
Tootsie Roll Industries
TR
$2.94B
$1.31M 0.04%
43,025
+340
+0.8% +$9.96K
RVTY icon
343
Revvity
RVTY
$12.4B
$1.3M 0.03%
11,917
+778
+7% +$75K
JJSF icon
344
J&J Snack Foods
JJSF
$1.49B
$1.3M 0.03%
7,756
+61
+0.8% +$9.92K
CRL icon
345
Charles River Laboratories
CRL
$11.6B
$1.29M 0.03%
5,464
-1,766
-24% -$347K
AVA icon
346
Avista
AVA
$3.46B
$1.29M 0.03%
36,063
+283
+0.8% +$9.59K
LTC
347
LTC Properties
LTC
$2.14B
$1.29M 0.03%
40,058
+317
+0.8% +$10.3K
DMC
348
Del Monte Corp
DMC
$1.37B
$1.28M 0.03%
48,588
+386
+0.8% +$9.5K
FIZZ icon
349
National Beverage
FIZZ
$3.05B
$1.27M 0.03%
25,508
+204
+0.8% +$9.76K
ULTA icon
350
Ulta Beauty
ULTA
$21.6B
$1.26M 0.03%
2,567
+238
+10% +$100K

Similar funds

Exchange Traded Concepts's Q4 2023 Portfolio in Review

As of Q4 2023, Exchange Traded Concepts held 1,456 positions worth $3.74B, up 5.9% from $3.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Exchange Traded Concepts withdrew a net $188M in Q4 2023, closing 232 positions and reducing 429 holdings. Its most notable exit was iShares 0-3 Month Treasury Bond ETF, an estimated $366M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Exchange Traded Concepts opened a new position in State Street Utilities Select Sector SPDR ETF worth $63M.

  • Exchange Traded Concepts's largest Q4 2023 buy was State Street Utilities Select Sector SPDR ETF: 1,990,668 shares worth $63M.
  • Exchange Traded Concepts added most to Vanguard Real Estate ETF in Q4 2023, an estimated $91.9M increase.
  • Exchange Traded Concepts's biggest Q4 2023 reduction was Vanguard Energy ETF, cutting an estimated $21.6M.
  • Exchange Traded Concepts fully exited iShares 0-3 Month Treasury Bond ETF in Q4 2023, selling an estimated $366M.
  • Exchange Traded Concepts's ten largest holdings make up 16% of its $3.74B portfolio in Q4 2023.
  • Exchange Traded Concepts opened 147 new positions and closed 232 in Q4 2023.
  • Exchange Traded Concepts's portfolio value rose 5.9% quarter-over-quarter to $3.74B.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.